An interventional study of study group in Enteral and Supplement Feeds Adverse Reaction and Peritonitis; Acute, sponsored by Université Evangélique enAfrique. Not yet recruiting. Open to participants aged 2 Years and older. Per ClinicalTrials.gov, last updated 2023-08-18.
Sponsored by Université Evangélique enAfrique · Not applicable, Interventional, and Supportive care
Hospitals in South Kivu always have problems supplying artificial enteral nutritional products because of their high cost and low availability in our areas. While the Province has cereals, knowing their nutritional composition would enable the formulation of a nutritional product based on local protein-energy products. Hence the questions below: Can a local cereal-based protein-energy ration be used instead of a costly imported artificial nutritional solution to improve the nutritional status of patients operated on for PAG? What is the tolerance of this early enteral nutrition on the healing and functional recovery of patients compared with an artificial nutritional solution? To answer these questions, a randomized clinical trial has been designed with the following objectives:
167 studies on the registry are indexed under Peritonitis; 23 are open to participants now.
This study's planned enrollment of 76 is close to the median of 79 across 106 interventional studies indexed under Peritonitis.
Browse Peritonitis studies →Université Evangélique enAfrique is the lead sponsor of 2 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
HIV
The human immunodeficiency virus, which weakens the immune system.
Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
an intervention arm consisting of patients who will receive the locally manufactured protein-energy ration after a laparotomy indicated for generalized acute peritonitis
Dietary Supplement: study group
patients who will receive the commercially available protein-energy ration after a laparotomy indicated for generalized acute peritonitis
Dietary Supplement: study group
Patients will receive early enteral locally nutrition postoperatively following surgery for peritonitis
Tolerability of feeding
We will screen complications after feeding
Time frame: 10 days after surgery
nutritional surveillance
changes in nutritional status using body mass index, albumin measurement, anthropometric data
Time frame: 2 days after, 5 days after, 10 days after feeding
No study locations are listed for this record.
Start is estimated for Aug 2023; primary completion for Oct 2023, 2 months later.
Of 23 interventional studies with no phase under Peritonitis, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 44. This study's planned 2 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Université Evangélique enAfrique